243 related articles for article (PubMed ID: 9352951)
1. Pathology of diffuse malignant pleural mesothelioma.
Corson JM
Semin Thorac Cardiovasc Surg; 1997 Oct; 9(4):347-55. PubMed ID: 9352951
[TBL] [Abstract][Full Text] [Related]
2. Pathology of mesothelioma.
Corson JM
Thorac Surg Clin; 2004 Nov; 14(4):447-60. PubMed ID: 15559051
[TBL] [Abstract][Full Text] [Related]
3. My approach to the diagnosis of mesothelial lesions.
Butnor KJ
J Clin Pathol; 2006 Jun; 59(6):564-74. PubMed ID: 16731600
[TBL] [Abstract][Full Text] [Related]
4. [Pleural mesothelioma: morphology, histochemistry, difficulties in diagnosis and nosologic problems (author's transl)].
Abelanet R; Jagueux M; Fondimare A; Roujeau J
Rev Fr Mal Respir; 1979; 7(3):243-64. PubMed ID: 91185
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry.
Bedrossian CW; Bonsib S; Moran C
Semin Diagn Pathol; 1992 May; 9(2):124-40. PubMed ID: 1609155
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid.
Kwee WS; Veldhuizen RW; Alons CA; Morawetz F; Boon ME
Acta Cytol; 1982; 26(4):401-6. PubMed ID: 6957089
[TBL] [Abstract][Full Text] [Related]
7. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
8. Problems in mesothelioma diagnosis.
Addis B; Roche H
Histopathology; 2009 Jan; 54(1):55-68. PubMed ID: 19054156
[TBL] [Abstract][Full Text] [Related]
9. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
10. Pathology of malignant mesothelioma.
Van Marck E
Lung Cancer; 2004 Aug; 45 Suppl 1():S35-6. PubMed ID: 15261431
[TBL] [Abstract][Full Text] [Related]
11. Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia. An immunohistochemical comparison.
Al-Izzi M; Thurlow NP; Corrin B
J Pathol; 1989 May; 158(1):41-4. PubMed ID: 2754539
[TBL] [Abstract][Full Text] [Related]
12. The role of immunohistochemistry in the diagnosis of malignant mesothelioma.
Moran CA; Wick MR; Suster S
Semin Diagn Pathol; 2000 Aug; 17(3):178-83. PubMed ID: 10968703
[TBL] [Abstract][Full Text] [Related]
13. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin as a marker for mesothelioma.
Kimura N; Kimura I
Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
[TBL] [Abstract][Full Text] [Related]
15. The pathology associated with therapeutic procedures in malignant mesothelioma.
Attanoos RL; Gibbs AR
Histopathology; 2004 Oct; 45(4):393-7. PubMed ID: 15469478
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
17. [Focal fibrous mesothelioma of the pleura (a morphological study of 7 cases].
Perevoshchikov AG; Katenkamp D; Raĭkhlin NT
Arkh Patol; 1989; 51(8):9-15. PubMed ID: 2479366
[TBL] [Abstract][Full Text] [Related]
18. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
19. [The problems of early diagnosis of diffuse malignant mesothelioma from the pathologo-anatomic view].
Schultz M; Kühne W
Zentralbl Pathol; 1992 Apr; 138(2):85-90. PubMed ID: 1610769
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
Tigrani DY; Weydert JA
Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
